The duration of lithium treatment was the only significant predictor for the development of hypercalcemia (p = 0.002).
Duration of pain (before amputation) is the most important predictor for the development of phantom limb pain.
In a multivariate analysis including several risk factors, only inhomogeneous myocardial perfusion turned out as an independent predictor for the development of allograft dysfunction.
Several studies have confirmed that chronic pain prior to amputation is a powerful predictor for the development of phantom limb pain [8].
In fact, abnormal tubular repair after AKI is thought to be one way to initiate CKD, and the severity of AKI is a robust predictor for the development of CKD [83].
Subgroup analysis showed that the cumulative duration of lithium use (i.e., the total time that a patient had used lithium regardless of any possible interruptions) was the only predictor for the development of hypercalcemia.
In a recent study, a reduced H/M ratio for 123I-mIBG has been identified as a predictor for the development of permanent AF and heart failure associated with permanent AF [8].
These data demonstrate that pretreatment serum EPCA is a significant predictor for the development of biochemical progression postoperatively in patients with clinically localized PCa.
Elevated EVLWI levels on day 1 of severe sepsis may serve as a predictor for the development of MODS and mortality during the patients' ICU stay.
This condition is a predictor for the development of diabetes.
Unacceptable acute pain is a strong predictor for the development of chronic thoracic pain.
